Evaluation of prognostic factors in patients with therapy-related acute myeloid leukemia

Blood Research

Volumn 48, Issue 3, 2013, Pages 185-192

  Park, Sang Hyuk ^a   Chi, Hyun Sook ^a   Cho, Young Uk ^a   Jang, Seongsoo ^a   Park, Chan Jeoung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

AML; Prognosis; Related; Therapy

Indexed keywords

ALKYLATING AGENT; CYTARABINE; DAUNORUBICIN; GYRASE INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FLT3 GENE; GENE; HUMAN; KARYOTYPE; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PHENOTYPE; TREATMENT OUTCOME;

EID: 84885806263     PISSN: 2287979X     EISSN: 22880011     Source Type: Journal    
DOI: 10.5045/br.2013.48.3.185     Document Type: Article

References (20)

1. Pedersen-Bjergaard J, Andersen MK, Johansson B. Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors. J Clin Oncol 1998;16: 1897-8.
2. Cortes J, O'Brien S, Kantarjian H, et al. Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes. Leukemia 1994;8:2174-8.
3. Quesnel B, Kantarjian H, Bjergaard JP, et al. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature. J Clin Oncol 1993;11:2370-9.
4. Leone G, Mele L, Pulsoni A, Equitani F, Pagano L. The incidence of secondary leukemias. Haematologica 1999;84:937-45.
5. Pui CH, Relling MV, Rivera GK, et al. Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases. Leukemia 1995; 9:1990-6.
6. Michels SD, McKenna RW, Arthur DC, Brunning RD. Therapyrelated acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood 1985;65: 1364-72.
7. Singh ZN, Huo D, Anastasi J, et al. Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Am J Clin Pathol 2007;127:197-205.
8. Grossmann V, Schnittger S, Kohlmann A, et al. A novel hierarchical prognostic model of AML solely based on molecular mutations. Blood 2012;120:2963-72.
9. Kuhnl A, Grimwade D. Molecular markers in acute myeloid leukaemia. Int J Hematol 2012;96:153-63.
10. Kayser S, Dohner K, Krauter J, et al. The impact of therapy- related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood 2011;117:2137-45.
11. Antonijevic N, Suvajdzic N, Terzic T, et al. Favourable prognostic factors in therapy related acute myeloid leukaemia. Srp Arh Celok Lek 2011;139:347-52.
12. Schoch C, Kern W, Schnittger S, Hiddemann W, Haferlach T. Karyotype is an independent prognostic parameter in therapyrelated acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia 2004;18:120-5.
13. Huh HJ, Lee SH, Yoo KH, et al. Therapy-related myeloid neoplasms in 39 Korean patients: a single institution experience. Ann Lab Med 2013;33:97-104.
14. Smith SM, Le Beau MM, Huo D, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003;102:43-52.
15. Shim H, Chi HS, Jang S, et al. Therapy-related acute leukemia in breast cancer patients: twelve cases treated with a topoisomerase inhibitor. Korean J Hematol 2010;45:177-82.
16. Andersen MK, Larson RA, Mauritzson N, Schnittger S, Jhanwar SC, Pedersen-Bjergaard J. Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002;33:395-400.
17. Detourmignies L, Castaigne S, Stoppa AM, et al. Therapy-related acute promyelocytic leukemia: a report on 16 cases. J Clin Oncol 1992;10:1430-5.
18. Beaumont M, Sanz M, Carli PM, et al. Therapy-related acute promyelocytic leukemia. J Clin Oncol 2003;21:2123-37.
19. Pulsoni A, Pagano L, Lo Coco F, et al. Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience. Blood 2002;100:1972-6.
20. Duffield AS, Aoki J, Levis M, et al. Clinical and pathologic features of secondary acute promyelocytic leukemia. Am J Clin Pathol 2012;137:395-402.